Le paludisme peut-il entraîner des complications graves ?
Oui, le paludisme peut causer des complications comme l'anémie sévère et le coma.
PaludismeComplications
#3
Comment gérer les complications transfusionnelles ?
La gestion inclut l'arrêt de la transfusion et le traitement des symptômes.
Réactions transfusionnellesTraitement médical
#4
Les complications sont-elles fréquentes avec le système Duffy ?
Les complications sont rares mais peuvent survenir en cas d'incompatibilité.
Système DuffyComplications médicales
#5
Quelles sont les conséquences d'une infection par le paludisme ?
Les conséquences incluent des défaillances organiques et des troubles neurologiques.
PaludismeConséquences
Facteurs de risque
5
#1
Quels sont les facteurs de risque pour le paludisme ?
Les facteurs incluent vivre dans des zones endémiques et ne pas utiliser de protection.
PaludismeFacteurs de risque
#2
Les groupes sanguins rares sont-ils à risque ?
Oui, les groupes sanguins rares peuvent avoir un risque accru d'incompatibilité.
Groupes sanguinsRisque transfusionnel
#3
Les antécédents transfusionnels augmentent-ils le risque ?
Oui, des antécédents transfusionnels peuvent augmenter le risque de réactions.
Antécédents médicauxRéactions transfusionnelles
#4
Les femmes enceintes sont-elles à risque avec Duffy ?
Oui, les femmes enceintes peuvent avoir des complications liées au système Duffy.
GrossesseSystème Duffy
#5
Les voyageurs sont-ils à risque de paludisme ?
Oui, les voyageurs vers des zones à risque doivent prendre des précautions.
VoyagePaludisme
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Système Duffy : Questions médicales les plus fréquentes",
"headline": "Système Duffy : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Système Duffy : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-28",
"dateModified": "2025-04-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Système Duffy"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Antigènes de groupe sanguin",
"url": "https://questionsmedicales.fr/mesh/D001789",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes de groupe sanguin",
"code": {
"@type": "MedicalCode",
"code": "D001789",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.230"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Système Duffy",
"alternateName": "Duffy Blood-Group System",
"code": {
"@type": "MedicalCode",
"code": "D004375",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Eugenia Lo",
"url": "https://questionsmedicales.fr/author/Eugenia%20Lo",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA."
}
},
{
"@type": "Person",
"name": "Delenasaw Yewhalaw",
"url": "https://questionsmedicales.fr/author/Delenasaw%20Yewhalaw",
"affiliation": {
"@type": "Organization",
"name": "Tropical and Infectious Diseases Research Center, Jimma University, Jimma, Ethiopia."
}
},
{
"@type": "Person",
"name": "Martin L Olsson",
"url": "https://questionsmedicales.fr/author/Martin%20L%20Olsson",
"affiliation": {
"@type": "Organization",
"name": "Medical Director of the Nordic Reference Laboratory for Genomic Blood Group Typing and Senior Consultant at the Department of Clinical Immunology and Transfusion Medicine, Office of Medical Services, Region Skåne; Professor of Transfusion Medicine at the Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, and Vice-Dean at the Faculty of Medicine, Lund University."
}
},
{
"@type": "Person",
"name": "Rei Rama",
"url": "https://questionsmedicales.fr/author/Rei%20Rama",
"affiliation": {
"@type": "Organization",
"name": "University of North Carolina at Charlotte."
}
},
{
"@type": "Person",
"name": "Lilian Castilho",
"url": "https://questionsmedicales.fr/author/Lilian%20Castilho",
"affiliation": {
"@type": "Organization",
"name": "Professor and Researcher, Hemocentro Campinas, University of Campinas, Rua Carlos Chagas."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Exploring the Genetic Predisposition to Epigenetic Changes in Alzheimer's Disease.",
"datePublished": "2023-04-27",
"url": "https://questionsmedicales.fr/article/37175659",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24097955"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Mendelian randomization study of genetic predisposition to autoimmune diseases and COVID-19.",
"datePublished": "2022-10-21",
"url": "https://questionsmedicales.fr/article/36271292",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-22711-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hemophagocytic Lymphohistiocytosis in Adolescents and Young Adults: Genetic Predisposition and Secondary Disease.",
"datePublished": "2023-07-11",
"url": "https://questionsmedicales.fr/article/37951650",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.mcna.2023.05.019"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genetic predisposition to cancers in children and adolescents.",
"datePublished": "2022-11-10",
"url": "https://questionsmedicales.fr/article/36354292",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MOP.0000000000001197"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genetic predisposition between coronavirus disease 2019 and rheumatic diseases: A 2-sample Mendelian randomization study.",
"datePublished": "2023-03-08",
"url": "https://questionsmedicales.fr/article/36890668",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1756-185X.14624"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Antigènes",
"item": "https://questionsmedicales.fr/mesh/D000941"
},
{
"@type": "ListItem",
"position": 4,
"name": "Isoantigènes",
"item": "https://questionsmedicales.fr/mesh/D007519"
},
{
"@type": "ListItem",
"position": 5,
"name": "Antigènes de groupe sanguin",
"item": "https://questionsmedicales.fr/mesh/D001789"
},
{
"@type": "ListItem",
"position": 6,
"name": "Système Duffy",
"item": "https://questionsmedicales.fr/mesh/D004375"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Système Duffy - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Système Duffy",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Système Duffy",
"description": "Comment déterminer le groupe sanguin Duffy ?\nQuels tests sont utilisés pour le système Duffy ?\nLe groupe Duffy peut-il changer ?\nQuels sont les types de groupes Duffy ?\nComment le groupe Duffy affecte-t-il les transfusions ?",
"url": "https://questionsmedicales.fr/mesh/D004375?mesh_terms=Genetic+Predisposition+to+Disease#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Système Duffy",
"description": "Quels symptômes sont liés à l'incompatibilité Duffy ?\nL'absence d'antigène Duffy cause-t-elle des symptômes ?\nLes infections sont-elles liées au système Duffy ?\nComment le système Duffy affecte-t-il la santé ?\nY a-t-il des symptômes spécifiques au paludisme ?",
"url": "https://questionsmedicales.fr/mesh/D004375?mesh_terms=Genetic+Predisposition+to+Disease#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Système Duffy",
"description": "Comment prévenir les incompatibilités Duffy ?\nY a-t-il des mesures préventives pour le paludisme ?\nLes donneurs de sang doivent-ils être testés ?\nComment sensibiliser sur le système Duffy ?\nLes vaccinations aident-elles contre le paludisme ?",
"url": "https://questionsmedicales.fr/mesh/D004375?mesh_terms=Genetic+Predisposition+to+Disease#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Système Duffy",
"description": "Comment traiter une réaction transfusionnelle Duffy ?\nY a-t-il un traitement pour l'absence d'antigène Duffy ?\nComment prévenir les réactions transfusionnelles ?\nLe paludisme a-t-il un traitement spécifique ?\nLes transfusions peuvent-elles être évitées ?",
"url": "https://questionsmedicales.fr/mesh/D004375?mesh_terms=Genetic+Predisposition+to+Disease#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Système Duffy",
"description": "Quelles complications peuvent survenir après une transfusion ?\nLe paludisme peut-il entraîner des complications graves ?\nComment gérer les complications transfusionnelles ?\nLes complications sont-elles fréquentes avec le système Duffy ?\nQuelles sont les conséquences d'une infection par le paludisme ?",
"url": "https://questionsmedicales.fr/mesh/D004375?mesh_terms=Genetic+Predisposition+to+Disease#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Système Duffy",
"description": "Quels sont les facteurs de risque pour le paludisme ?\nLes groupes sanguins rares sont-ils à risque ?\nLes antécédents transfusionnels augmentent-ils le risque ?\nLes femmes enceintes sont-elles à risque avec Duffy ?\nLes voyageurs sont-ils à risque de paludisme ?",
"url": "https://questionsmedicales.fr/mesh/D004375?mesh_terms=Genetic+Predisposition+to+Disease#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment déterminer le groupe sanguin Duffy ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le groupe sanguin Duffy est déterminé par des tests sérologiques spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le système Duffy ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'agglutination et des tests d'anticorps sont utilisés pour le système Duffy."
}
},
{
"@type": "Question",
"name": "Le groupe Duffy peut-il changer ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, le groupe sanguin Duffy est déterminé génétiquement et ne change pas."
}
},
{
"@type": "Question",
"name": "Quels sont les types de groupes Duffy ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux groupes Duffy sont Fya et Fyb, avec des variations possibles."
}
},
{
"@type": "Question",
"name": "Comment le groupe Duffy affecte-t-il les transfusions ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une incompatibilité Duffy peut entraîner des réactions transfusionnelles."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à l'incompatibilité Duffy ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des réactions allergiques, fièvre et anémie."
}
},
{
"@type": "Question",
"name": "L'absence d'antigène Duffy cause-t-elle des symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'absence d'antigène Duffy n'entraîne généralement pas de symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Les infections sont-elles liées au système Duffy ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections, comme le paludisme, sont influencées par le système Duffy."
}
},
{
"@type": "Question",
"name": "Comment le système Duffy affecte-t-il la santé ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il influence la susceptibilité aux infections et les réactions transfusionnelles."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques au paludisme ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes du paludisme incluent fièvre, frissons, et douleurs musculaires."
}
},
{
"@type": "Question",
"name": "Comment prévenir les incompatibilités Duffy ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par des tests sanguins avant toute transfusion."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives pour le paludisme ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'utilisation de moustiquaires et de répulsifs aide à prévenir le paludisme."
}
},
{
"@type": "Question",
"name": "Les donneurs de sang doivent-ils être testés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, tous les donneurs de sang doivent être testés pour les groupes sanguins."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser sur le système Duffy ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des campagnes d'information peuvent sensibiliser sur l'importance des tests sanguins."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles contre le paludisme ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent réduire le risque d'infection par le paludisme."
}
},
{
"@type": "Question",
"name": "Comment traiter une réaction transfusionnelle Duffy ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut l'arrêt de la transfusion et la gestion des symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il un traitement pour l'absence d'antigène Duffy ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'y a pas de traitement nécessaire pour l'absence d'antigène Duffy."
}
},
{
"@type": "Question",
"name": "Comment prévenir les réactions transfusionnelles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par des tests de compatibilité rigoureux avant transfusion."
}
},
{
"@type": "Question",
"name": "Le paludisme a-t-il un traitement spécifique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le paludisme est traité avec des antipaludiques comme la chloroquine."
}
},
{
"@type": "Question",
"name": "Les transfusions peuvent-elles être évitées ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des alternatives comme les médicaments ou les transfusions autologues peuvent être utilisées."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une transfusion ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des réactions allergiques, hémolyse et choc transfusionnel."
}
},
{
"@type": "Question",
"name": "Le paludisme peut-il entraîner des complications graves ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le paludisme peut causer des complications comme l'anémie sévère et le coma."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications transfusionnelles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut l'arrêt de la transfusion et le traitement des symptômes."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes avec le système Duffy ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont rares mais peuvent survenir en cas d'incompatibilité."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une infection par le paludisme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les conséquences incluent des défaillances organiques et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour le paludisme ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent vivre dans des zones endémiques et ne pas utiliser de protection."
}
},
{
"@type": "Question",
"name": "Les groupes sanguins rares sont-ils à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les groupes sanguins rares peuvent avoir un risque accru d'incompatibilité."
}
},
{
"@type": "Question",
"name": "Les antécédents transfusionnels augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents transfusionnels peuvent augmenter le risque de réactions."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles à risque avec Duffy ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes enceintes peuvent avoir des complications liées au système Duffy."
}
},
{
"@type": "Question",
"name": "Les voyageurs sont-ils à risque de paludisme ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyageurs vers des zones à risque doivent prendre des précautions."
}
}
]
}
]
}
Medical Director of the Nordic Reference Laboratory for Genomic Blood Group Typing and Senior Consultant at the Department of Clinical Immunology and Transfusion Medicine, Office of Medical Services, Region Skåne; Professor of Transfusion Medicine at the Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, and Vice-Dean at the Faculty of Medicine, Lund University.
Immunohematology, Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine, Office for Medical Services , Akutgatan 8, SE-22185, Lund , Sweden.
Department of Pathology, Hale Building for Transformative Medicine, Brigham and Women's Hospital, Rm 8002L, 60 Fenwood Rd, Boston, MA, 02115, USA. wlane@bwh.harvard.edu.
Harvard Medical School, Boston, MA, USA. wlane@bwh.harvard.edu.
Associate Professor, Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, and Technical Director of Immunohematology Laboratories, Department of Clinical Immunology and Transfusion Medicine, Office for Medical Services, Lund, Sweden.
Alzheimer's disease (AD) is a prevalent type of dementia in elderly populations with a significant genetic component. The accumulating evidence suggests that AD involves a reconfiguration of the epige...
Autoimmune diseases and coronavirus disease 2019 (COVID-19) share many similarities. Concerns have arisen that autoimmune diseases may increase the susceptibility and severity of COVID-19. We used Men...
Hemophagocytic lymphohistiocytosis (HLH) is a disorder of impaired immune regulation resulting in hyperinflammation that is ultimately fatal if not treated. HLH is categorized into familial disease, c...
Childhood cancer is rare, but it remains the leading cause of disease-related mortality among children 1-14 years of age. As exposure to environmental factors is lower in children, inherited genetic f...
Current literature suggests that 10-18% of paediatric cancer patients have an underlying genetic susceptibility to their disease. With better knowledge and technology, more genes and syndromes are bei...
This review summarizes the current knowledge about different cancer predisposition syndromes, focusing on the diagnosis, genetic counselling, surveillance and future directions....
The causalities between the coronavirus disease 2019 (COVID-19) and the risk of rheumatic diseases remain unclear. The purpose of this study was to investigate the causal effect of COVID-19 on rheumat...
Single nucleotide polymorphisms (SNPs), acquired from published genome-wide association studies, were used to perform 2-sample Mendelian randomization (MR) on cases diagnosed with COVID-19 (n = 13 464...
The results revealed a causality between COVID-19 and rheumatic diseases with an odds ratio (OR) of 1.010 (95% confidence interval [CI], 1.006-1.013; P = .014). In addition, we observed that COVID-19 ...
This is the first study to use MR to explore the impact of COVID-19 on rheumatic diseases. From a genetic perspective, we found that COVID-19 could increase the risk of rheumatic diseases, such as PBC...
Diets rich in plant-based foods are associated with lower risks of non-alcoholic fatty liver disease (NAFLD), while the prospective evidence is limited. We aimed to examine longitudinal associations o...
This longitudinal cohort study included 159,222 participants (58.0 ± 8.0 years old, 55.7% female) free of NAFLD in the UK Biobank. We calculated the overall plant-based diet index (PDI), the healthful...
During a median follow-up of 9.5 years, 1541 new-onset NAFLD cases were documented. Compared to the lowest quintile, multivariable-adjusted hazard ratios (HRs) of NAFLD in the highest quintile were 0....
Higher intake of plant-based diets especially healthful plant-based diets was associated with lower NAFLD risk and liver fat content regardless of genetic susceptibility, whereas an unhealthful plant-...
Accumulating evidence has indicated that persistent human cytomegalovirus (HCMV) infection is associated with several cardiovascular diseases including atherosclerosis and coronary artery disease. How...
Single-nucleotide polymorphisms associated with anti-cytomegalovirus immunoglobulin (Ig) G levels were used as instrumental variables to estimate the causal effect of anti-cytomegalovirus IgG levels o...
In the IVW analysis, genetically predicted anti-cytomegalovirus IgG levels were suggestively associated with coronary artery disease with an odds ratio (OR) of 1.076 [95% CI, 1.009-1.147; p = 0.025], ...
Our findings first provide direct evidence that genetic predisposition of anti-cytomegalovirus IgG levels increases the risk of coronary artery disease, peripheral artery disease, and deep vein thromb...
The implementation of next-generation sequencing technologies has provided a sharp picture of the genetic variability in the components and regulators of the alternative pathway (AP) of the complement...
Current evidence on the relations of residential greenness with glucose homeostasis and type 2 diabetes (T2D) remained largely uncertain. Most importantly, no prior studies have investigated whether g...
We leveraged data from the UK Biobank prospective cohort study, with participants enrolled between 2006 and 2010. Residential greenness was assessed by using the Normalized Difference Vegetation Index...
Among 315,146 individuals (mean [SD] age, 56.59 [8.09] years), each one-unit increase in residential greenness was associated with reduction in HbA...
We add novel evidence that residential greenness has protective effects on glucose metabolism and T2D, and those beneficial effects can be amplified by low genetic risk. Our findings may facilitate th...
Thyroid hormones have actions on cartilage, whereas the association between thyroid hormone related diseases and osteoarthritis (OA) are unclear. This study aims to investigate the association between...
Summary-level genetic data of thyrotoxicosis were obtained from FinnGen cohorts (nCase = 10,569, nControl = 762,037). Summary-level data of OA were obtained from a large-scale genome-wide association ...
Genetic predisposition of thyrotoxicosis was associated with the onset of knee OA (autoimmune hyperthyroidism: odds ratio [OR]: 1.05, 95% confidence interval [CI]: 1.03-1.07, FDR < 0.001; thyrotoxicos...
This study provides MR evidence supporting causal association of thyrotoxicosis with knee OA in European population, whereas OA may have no causal effects on thyrotoxicosis....